Signaling through hepatocyte vasopressin receptor 1 protects mouse liver from ischemia-reperfusion injury

Terlipressin has been used extensively in the management of certain complications associated with end-stage liver diseases (ESLDs). In our pilot study, terlipressin treatment showed beneficial effects on liver function in patients with decompensated cirrhosis, however whether it plays a role in live...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xiqiang, Luo, Gaojian, Jiang, Jingbo, Ma, Tonghui, Lin, Xiaozhu, Jiang, Liping, Cheng, Jilin, Tao, Ran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper: Pathology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342477/
https://www.ncbi.nlm.nih.gov/pubmed/27713143
http://dx.doi.org/10.18632/oncotarget.12472

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342477/
https://www.ncbi.nlm.nih.gov/pubmed/27713143
http://dx.doi.org/10.18632/oncotarget.12472

Ejemplares similares